Victoria A Risner1, Chelsie E Benca-Bachman1, Lauren Bertin1, Alicia K Smith2, Jaakko Kaprio3,4, John E McGeary5,6, Elissa Chesler7, Valerie S Knopik8, Naomi P Friedman9, Rohan H C Palmer1. 1. Behavioral Genetics of Addiction Laboratory, Department of Psychology, Emory University, Atlanta, GA, USA. 2. Smith Lab, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, USA. 3. Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. 4. Department of Public Health, University of Helsinki, Helsinki, Finland. 5. Department of Psychiatry & Human Behavior, Brown University, Providence, RI, USA. 6. The Genomic Laboratory, Providence VA Medical Center, Providence, RI, USA. 7. The Jackson Laboratory, Bar Harbor, ME, USA. 8. Department of Human Development and Family Studies, College of Health and Human Sciences, Purdue University, West Lafayette, IN, USA. 9. Department of Psychology, University of Colorado at Boulder, Boulder, CO, USA.
Abstract
INTRODUCTION: Heritability estimates of nicotine dependence (ND) range from 40% to 70%, but discovery GWAS of ND are underpowered and have limited predictive utility. In this work, we leverage genetically correlated traits and diseases to increase the accuracy of polygenic risk prediction. METHODS: We employed a multi-trait model using summary statistic-based best linear unbiased predictors (SBLUP) of genetic correlates of DSM-IV diagnosis of ND in 6394 individuals of European Ancestry (prevalence = 45.3%, %female = 46.8%, µ age = 40.08 [s.d. = 10.43]) and 3061 individuals from a nationally-representative sample with Fagerström Test for Nicotine Dependence symptom count (FTND; 51.32% female, mean age = 28.9 [s.d. = 1.70]). Polygenic predictors were derived from GWASs known to be phenotypically and genetically correlated with ND (i.e., Cigarettes per Day [CPD], the Alcohol Use Disorders Identification Test [AUDIT-Consumption and AUDIT-Problems], Neuroticism, Depression, Schizophrenia, Educational Attainment, Body Mass Index [BMI], and Self-Perceived Risk-Taking); including Height as a negative control. Analyses controlled for age, gender, study site, and the first 10 ancestral principal components. RESULTS: The multi-trait model accounted for 3.6% of the total trait variance in DSM-IV ND. Educational Attainment (β = -0.125; 95% CI: [-0.149,-0.101]), CPD (0.071 [0.047,0.095]), and Self-Perceived Risk-Taking (0.051 [0.026,0.075]) were the most robust predictors. PGS effects on FTND were limited. CONCLUSIONS: Risk for ND is not only polygenic, but also pleiotropic. Polygenic effects on ND that are accessible by these traits are limited in size and act additively to explain risk. IMPLICATIONS: These findings enhance our understanding of inherited genetic factors for nicotine dependence. The data show that genome-wide association study (GWAS) findings across pre- and comorbid conditions of smoking are differentially associated with nicotine dependence and that when combined explain significantly more trait variance. These findings underscore the utility of multivariate approaches to understand the validity of polygenic scores for nicotine dependence, especially as the power of GWAS of broadly-defined smoking behaviors increases. Realizing the potential of GWAS to inform complex smoking behaviors will require similar theory-driven models that reflect the myriad of mechanisms that drive individual differences.
INTRODUCTION: Heritability estimates of nicotine dependence (ND) range from 40% to 70%, but discovery GWAS of ND are underpowered and have limited predictive utility. In this work, we leverage genetically correlated traits and diseases to increase the accuracy of polygenic risk prediction. METHODS: We employed a multi-trait model using summary statistic-based best linear unbiased predictors (SBLUP) of genetic correlates of DSM-IV diagnosis of ND in 6394 individuals of European Ancestry (prevalence = 45.3%, %female = 46.8%, µ age = 40.08 [s.d. = 10.43]) and 3061 individuals from a nationally-representative sample with Fagerström Test for Nicotine Dependence symptom count (FTND; 51.32% female, mean age = 28.9 [s.d. = 1.70]). Polygenic predictors were derived from GWASs known to be phenotypically and genetically correlated with ND (i.e., Cigarettes per Day [CPD], the Alcohol Use Disorders Identification Test [AUDIT-Consumption and AUDIT-Problems], Neuroticism, Depression, Schizophrenia, Educational Attainment, Body Mass Index [BMI], and Self-Perceived Risk-Taking); including Height as a negative control. Analyses controlled for age, gender, study site, and the first 10 ancestral principal components. RESULTS: The multi-trait model accounted for 3.6% of the total trait variance in DSM-IV ND. Educational Attainment (β = -0.125; 95% CI: [-0.149,-0.101]), CPD (0.071 [0.047,0.095]), and Self-Perceived Risk-Taking (0.051 [0.026,0.075]) were the most robust predictors. PGS effects on FTND were limited. CONCLUSIONS: Risk for ND is not only polygenic, but also pleiotropic. Polygenic effects on ND that are accessible by these traits are limited in size and act additively to explain risk. IMPLICATIONS: These findings enhance our understanding of inherited genetic factors for nicotine dependence. The data show that genome-wide association study (GWAS) findings across pre- and comorbid conditions of smoking are differentially associated with nicotine dependence and that when combined explain significantly more trait variance. These findings underscore the utility of multivariate approaches to understand the validity of polygenic scores for nicotine dependence, especially as the power of GWAS of broadly-defined smoking behaviors increases. Realizing the potential of GWAS to inform complex smoking behaviors will require similar theory-driven models that reflect the myriad of mechanisms that drive individual differences.
Authors: Rohan H C Palmer; Tanya M Button; Soo H Rhee; Robin P Corley; Susan E Young; Michael C Stallings; Christian J Hopfer; John K Hewitt Journal: Drug Alcohol Depend Date: 2012-01-11 Impact factor: 4.492
Authors: Li-Shiun Chen; Sarah M Hartz; Timothy B Baker; Yinjiao Ma; Nancy L Saccone; Laura J Bierut Journal: Pharmacogenomics Date: 2018-11-16 Impact factor: 2.533
Authors: Lun-Hsien Chang; Baptiste Couvy-Duchesne; Mengzhen Liu; Sarah E Medland; Brad Verhulst; Eric G Benotsch; Ian B Hickie; Nicholas G Martin; Nathan A Gillespie Journal: Drug Alcohol Depend Date: 2019-02-16 Impact factor: 4.492
Authors: Andries T Marees; Anke R Hammerschlag; Lisa Bastarache; Hilde de Kluiver; Florence Vorspan; Wim van den Brink; Dirk J Smit; Damiaan Denys; Eric R Gamazon; Ruifang Li-Gao; Elemi J Breetvelt; Mark C H de Groot; Tessel E Galesloot; Sita H Vermeulen; Jan L Poppelaars; Patrick C Souverein; Renske Keeman; Renée de Mutsert; Raymond Noordam; Frits R Rosendaal; Najada Stringa; Dennis O Mook-Kanamori; Ilonca Vaartjes; Lambertus A Kiemeney; Martin den Heijer; Natasja M van Schoor; Olaf H Klungel; Anke H Maitland-Van der Zee; Marjanka K Schmidt; Tinca J C Polderman; Andries R van der Leij; Danielle Posthuma; Eske M Derks Journal: Drug Alcohol Depend Date: 2018-04-25 Impact factor: 4.492
Authors: Gerome Breen; Thalia C Eley; Kirstin L Purves; Jonathan R I Coleman; Sandra M Meier; Christopher Rayner; Katrina A S Davis; Rosa Cheesman; Marie Bækvad-Hansen; Anders D Børglum; Shing Wan Cho; J Jürgen Deckert; Héléna A Gaspar; Jonas Bybjerg-Grauholm; John M Hettema; Matthew Hotopf; David Hougaard; Christopher Hübel; Carol Kan; Andrew M McIntosh; Ole Mors; Preben Bo Mortensen; Merete Nordentoft; Thomas Werge; Kristin K Nicodemus; Manuel Mattheisen Journal: Mol Psychiatry Date: 2019-11-20 Impact factor: 15.992
Authors: Henry R Kranzler; Hang Zhou; Rachel L Kember; Rachel Vickers Smith; Amy C Justice; Scott Damrauer; Philip S Tsao; Derek Klarin; Aris Baras; Jeffrey Reid; John Overton; Daniel J Rader; Zhongshan Cheng; Janet P Tate; William C Becker; John Concato; Ke Xu; Renato Polimanti; Hongyu Zhao; Joel Gelernter Journal: Nat Commun Date: 2019-04-02 Impact factor: 14.919
Authors: Sandra Sanchez-Roige; Abraham A Palmer; Pierre Fontanillas; Sarah L Elson; Mark J Adams; David M Howard; Howard J Edenberg; Gail Davies; Richard C Crist; Ian J Deary; Andrew M McIntosh; Toni-Kim Clarke Journal: Am J Psychiatry Date: 2018-10-19 Impact factor: 18.112
Authors: Bryan C Quach; Michael J Bray; Nathan C Gaddis; Mengzhen Liu; Teemu Palviainen; Camelia C Minica; Stephanie Zellers; Richard Sherva; Fazil Aliev; Michael Nothnagel; Kendra A Young; Jesse A Marks; Hannah Young; Megan U Carnes; Yuelong Guo; Alex Waldrop; Nancy Y A Sey; Maria T Landi; Daniel W McNeil; Dmitriy Drichel; Lindsay A Farrer; Christina A Markunas; Jacqueline M Vink; Jouke-Jan Hottenga; William G Iacono; Henry R Kranzler; Nancy L Saccone; Michael C Neale; Pamela Madden; Marcella Rietschel; Mary L Marazita; Matthew McGue; Hyejung Won; Georg Winterer; Richard Grucza; Danielle M Dick; Joel Gelernter; Neil E Caporaso; Timothy B Baker; Dorret I Boomsma; Jaakko Kaprio; John E Hokanson; Scott Vrieze; Laura J Bierut; Eric O Johnson; Dana B Hancock Journal: Nat Commun Date: 2020-11-03 Impact factor: 17.694